Epidermal Growth Factor Receptor: Is It a Feasible Target for the Treatment of Osteosarcoma?
Jun Ah Lee, Yunmi Ko, Dong Ho Kim, Jung Sub Lim, Chang-Bae Kong, Wan Hyeong Cho, Dae-Geun Jeon, Soo-Yong Lee, Jae-Soo Koh
Cancer Res Treat. 2012;44(3):202-209.   Published online 2012 Sep 30     DOI: https://doi.org/10.4143/crt.2012.44.3.202
Citations to this article as recorded by Crossref logo
PD-L1, STAT3, IL6, and EGFR Immunoexpressions in High-Grade Osteosarcoma
Nayla Rahmadiani, Eviana Norahmawati, Agustina Tri Endharti, Ailen Oktaviana Hambalie, Satria Pandu Persada Isma, Raffaele Vitiello
Advances in Orthopedics.2024; 2024: 1.     CrossRef
EGFR-targeting peptide conjugated polymer–lipid hybrid nanoparticles for delivery of salinomycin to osteosarcoma
Longhai Du, Yanlong Xu, Binxu Han, Yu Wang, Qingmin Zeng, Minghao Shao, Zuochong Yu
Journal of Cancer Research and Therapeutics.2023; 19(6): 1544.     CrossRef
Epidermal growth factor signalling pathway in endochondral ossification: an evidence-based narrative review
L. Mangiavini, G. M. Peretti, B. Canciani, N. Maffulli
Annals of Medicine.2022; 54(1): 37.     CrossRef
Stattic sensitizes osteosarcoma cells to epidermal growth factor receptor inhibitors via blocking the interleukin 6-induced STAT3 pathway
Shenglin Wang, Yunqing Wang, Zhen Huang, Hongxiang Wei, Xinwen Wang, Rongkai Shen, Wenbin Lan, Guangxian Zhong, Jianhua Lin
Acta Biochimica et Biophysica Sinica.2021; 53(12): 1670.     CrossRef
Afatinib is active in osteosarcoma in osteosarcoma cell lines
Marlid Cruz-Ramos, Yessica Zamudio-Cuevas, Daniel Medina-Luna, Karina Martínez-Flores, Gabriela Martínez-Nava, Javier Fernández-Torres, Alberto López-Reyes, Flavio Solca
Journal of Cancer Research and Clinical Oncology.2020; 146(7): 1693.     CrossRef
The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas
Xiaochun Wang, Reichelle X. Yeo, Philip J. Hogg, David Goldstein, Philip Crowe, Pierre J. Dilda, Jia-Lin Yang
Oncotarget.2020; 11(1): 46.     CrossRef
Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies
Ingrid Lilienthal, Nikolas Herold
International Journal of Molecular Sciences.2020; 21(18): 6885.     CrossRef
Prospects for NK Cell Therapy of Sarcoma
Mieszko Lachota, Marianna Vincenti, Magdalena Winiarska, Kjetil Boye, Radosław Zagożdżon, Karl-Johan Malmberg
Cancers.2020; 12(12): 3719.     CrossRef
Advanced development of ErbB family-targeted therapies in osteosarcoma treatment
Wei Wang, Hua-fu Zhao, Teng-fei Yao, Hao Gong
Investigational New Drugs.2019; 37(1): 175.     CrossRef
The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells
Tian Wang, Dexing Wang, Lian Zhang, Ping Yang, Jing Wang, Qi Liu, Fei Yan, Feng Lin
Journal of Experimental & Clinical Cancer Research.2019;[Epub]     CrossRef
Interpretation of Tongue Squamous Cell Carcinoma via Protein-Protein Interaction Network Construction and Analysis
Mona Zamanian Azodi, Mostafa Rezaei-Tavirani, Majid Rezaei-Tavirani, Vahid Mansouri, Reza Vafaee
International Journal of Cancer Management.2018;[Epub]     CrossRef
EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling
Markus Linder, Elisabeth Glitzner, Sriram Srivatsa, Latifa Bakiri, Kazuhiko Matsuoka, Parastoo Shahrouzi, Monika Dumanic, Philipp Novoszel, Thomas Mohr, Oliver Langer, Thomas Wanek, Markus Mitterhauser, Erwin F Wagner, Maria Sibilia
EMBO Molecular Medicine.2018;[Epub]     CrossRef
Prognostic significance of the expression of HER family members in primary osteosarcoma
Sheng‑Lin Wang, Guang‑Xian Zhong, Xin‑Wen Wang, Feng‑Qiang Yu, Dan‑Feng Weng, Xin‑Xing Wang, Jian‑Hua Lin
Oncology Letters.2018;[Epub]     CrossRef
Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells
Fernanda B. Mantovani, Jodi A. Morrison, Anthony J. Mutsaers
BMC Veterinary Research.2016;[Epub]     CrossRef
Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma
Sara Westrøm, Tina B. Bønsdorff, Nasir Abbas, Øyvind S. Bruland, Thora J. Jonasdottir, Gunhild M. Mælandsmo, Roy H. Larsen, Salvatore V Pizzo
PLOS ONE.2016; 11(10): e0165382.     CrossRef
Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies
Pierre J. Marie
Cellular and Molecular Life Sciences.2015; 72(7): 1347.     CrossRef
Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers
Aude I. Ségaliny, Marta Tellez-Gabriel, Marie-Françoise Heymann, Dominique Heymann
Journal of Bone Oncology.2015; 4(1): 1.     CrossRef
EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance
Florian Sevelda, Lisa Mayr, Bernd Kubista, Daniela Lötsch, Sushilla van Schoonhoven, Reinhard Windhager, Christine Pirker, Michael Micksche, Walter Berger
Journal of Experimental & Clinical Cancer Research.2015;[Epub]     CrossRef
Amphiregulin enhances intercellular adhesion molecule-1 expression and promotes tumor metastasis in human osteosarcoma
Ju-Fang Liu, Ya-Ting Tsao, Chun-Han Hou
Oncotarget.2015; 6(38): 40880.     CrossRef
ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib
Jiani Liu, Jiangxue Wu, Ling Zhou, Changchuan Pan, Yi Zhou, Wuying Du, Jie-min Chen, Xiaofeng Zhu, Jingnan Shen, Shuai Chen, Ran-yi Liu, Wenlin Huang
Oncotarget.2015; 6(25): 21341.     CrossRef
Molecular profiling of childhood cancer: Biomarkers and novel therapies
Federica Saletta, Carol Wadham, David S. Ziegler, Glenn M. Marshall, Michelle Haber, Geoffrey McCowage, Murray D. Norris, Jennifer A. Byrne
BBA Clinical.2014; 1: 59.     CrossRef
ErbB Receptors as Prognostic and Therapeutic Drug Targets in Bone and Soft Tissue Sarcomas
Hongsheng Wang, Qingbo Yang, Zeze Fu, Dongqing Zuo, Yingqi Hua, Zhengdong Cai
Cancer Investigation.2014; 32(10): 533.     CrossRef
Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models
Bérengère Gobin, Gatien Moriceau, Benjamin Ory, Céline Charrier, Régis Brion, Frederic Blanchard, Françoise Redini, Dominique Heymann, Gerard Roel Rutteman
PLoS ONE.2014; 9(3): e90795.     CrossRef
Focal Chromosomal Copy Number Aberrations Identify CMTM8 and GPR177 as New Candidate Driver Genes in Osteosarcoma
Joeri Both, Oscar Krijgsman, Johannes Bras, Gerard R. Schaap, Frank Baas, Bauke Ylstra, Theo J. M. Hulsebos, David Loeb
PLoS ONE.2014; 9(12): e115835.     CrossRef
Gefitinib and Luteolin Cause Growth Arrest of Human Prostate Cancer PC-3 Cells via Inhibition of Cyclin G-Associated Kinase and Induction of miR-630
Minami A. Sakurai, Yuki Ozaki, Daisuke Okuzaki, Yoko Naito, Towa Sasakura, Ayumi Okamoto, Hiroe Tabara, Takao Inoue, Man Hagiyama, Akihiko Ito, Norikazu Yabuta, Hiroshi Nojima, Ichiro Aoki
PLoS ONE.2014; 9(6): e100124.     CrossRef
Clinical Predictive Value of Serum Angiogenic Factor in Patients with Osteosarcoma
Zhe Chen, Qi-Xin Chen, Zhao-Yang Hou, Jiong Hu, Yan-Guang Cao
Asian Pacific Journal of Cancer Prevention.2012; 13(9): 4823.     CrossRef